Karin H. Herbschleb

Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> Mutations

Christian Menzer, Alexander M. Menzies, Matteo S. Carlino et al. · Journal of Clinical Oncology · 2019 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Koen P. Rovers, Checca Bakkers, Geert A. Simkens et al. · BMC Cancer · 2019 · 111 citations · Full text

Medicine, Oncology, Surgery +14

First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity

Sophie Postel‐Vinay, Karin H. Herbschleb, Christophe Massard et al. · European Journal of Cancer · 2019 · 104 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol et al. · European Journal of Cancer · 2020 · 78 citations · Full text

Medicine, Oncology, Cancer Epidemiology +4

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases

Koen P. Rovers, Checca Bakkers, Simon W. Nienhuijs et al. · JAMA Surgery · 2021 · 73 citations · Full text

Medicine, Perioperative Medicine, Surgery +17